Work

Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC

Year: 2019

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.10.022

Authors: Wan Ling Tan, Kevin L.M. Chua, Chia-Chi Lin, Victor H.F. Lee, Lye Mun Tho, Anthony W. Chan, Gwo Fuang Ho, Thanyanan Reungwetwattana, James C. Yang, Dong-Wan Kim, Ross A. Soo, Yong Chan Ahn, Hiroshi Onishi, Myung-Ju Ahn, Tony S.K. Mok, Daniel S.W. Tan, Fan Yang

Institutions: National Cancer Centre Singapore, National Taiwan University Hospital, University of Hong Kong, Chinese University of Hong Kong, University Malaya Medical Centre, Mahidol University, Ramathibodi Hospital, Seoul National University, Seoul National University Hospital, National University Hospital, Samsung Medical Center, Sungkyunkwan University, University of Yamanashi, SingHealth, Peking University People's Hospital

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Roche, American Society of Clinical Oncology, Takeda Pharmaceutical Company, Clovis Oncology, Chinese Society of Clinical Oncology, Merck Sharp and Dohme

OpenAlex ID: W2985099633

FWCI: 4.042

Cites: 88

Cited by: 55

Related to: 10